HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hb Heathrow [β103(G5)Phe→Leu], a First Report in an Asian Patient with Erythrocytosis.

Abstract
Congenital erythrocytosis (CE) is a rare and heterogeneous disease. The high oxygen affinity hemoglobin (Hb) variants are the most common cause of CE. Herein, we report a Korean patient with isolated erythrocytosis. A 25-year-old man was referred to our hospital for evaluation of high Hb level (Hb 20.4 g/dL, hematocrit 58%, reticulocyte count 2.90%, white blood cell count 6.83×10⁹/L, and platelet count 195×10⁹/L). Bone marrow biopsy revealed normocellular marrow without myeloproliferative features. JAK2 (V617F, exon 12), CALR (exon 9), and MPL W515K/L mutations were not detected. P₅₀ (partial pressure at which Hb is half saturated with oxygen), which is an indicator of left-shift of oxygen dissociation curve (high oxygen affinity state), was 14.3 mm Hg (reference value 22.6-29.4 mm Hg). He was suspected to have CE. Mutation analysis of the HBB gene revealed the known Hb variant, Hb Heathrow [β103(G5)Phe→Leu]. This is the first report of Hb Heathrow in Asian.
AuthorsSang Yong Shin, Hyun Young Kim, Hee Jin Kim, Hoon Gu Kim
JournalYonsei medical journal (Yonsei Med J) Vol. 58 Issue 3 Pg. 665-667 (May 2017) ISSN: 1976-2437 [Electronic] Korea (South)
PMID28332377 (Publication Type: Case Reports)
Copyright© Copyright: Yonsei University College of Medicine 2017.
Chemical References
  • Hemoglobins, Abnormal
  • hemoglobin Heathrow
  • JAK2 protein, human
  • Janus Kinase 2
  • Oxygen
Topics
  • Adult
  • Biopsy
  • Bone Marrow (pathology)
  • DNA Mutational Analysis
  • Exons (genetics)
  • Frameshift Mutation
  • Hemoglobins, Abnormal (genetics, isolation & purification, metabolism)
  • Humans
  • Janus Kinase 2
  • Male
  • Mutation
  • Oxygen (metabolism)
  • Polycythemia (blood, genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: